Where does Claris Bio's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Claris Bio's 1 recorded funding rounds.

Premier Alternatives

Claris Bio

Drug Discovery · Jersey City, NJ · Founded 2018 · Privately Held (backing)

Developer of a topical formulation technology designed to treat orphan ophthalmic disorders. Claris Bio is based in Jersey City, NJ and was founded in 2018. It was valued at $163 million at its later-stage round in Nov 2025, the last priced event on record. It has raised $154 million across 1 recorded round; the latest was a $54.5 million Series A in Jan 2024.

PMV mark · valuation

$163.4M

Oct 2026

Priced at

its later-stage round

Nov 2025

Total raised

$153.6M

Last round

Later Stage VC (Series A)

Jan 2024

Cap table — not yet on record

Claris Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Claris Bio with a free account

·Watch Claris Bio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Claris Bio

Where does Claris Bio's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Claris Bio's 1 recorded funding rounds.